In this work we propose a comprehensive framework based on first-order logic (FOL) 1 for mitigating (identifying and addressing) interactions between multiple clinical practice guidelines (CPGs) applied to a multi-morbid patient while also considering patient preferences related to the prescribed treatment. With this framework we respond to two fundamental challenges associated with clinical decision support: (1) concurrent application of multiple CPGs and (2) incorporation of patient preferences into the decision making process.
plied to a multi-morbid patient while also considering patient preferences related to the prescribed treatment. With this framework we respond to two fundamental challenges associated with clinical decision support: (1) concurrent application of multiple CPGs and (2) incorporation of patient preferences into the decision making process.
We significantly expand our earlier research by (1) proposing a revised and improved mitigationoriented representation of CPGs and secondary medical knowledge for addressing adverse interactions and incorporating patient preferences and (2) introducing a new mitigation algorithm. Specifically, actionable graphs representing CPGs allow for parallel and temporal activities (decisions and actions). Revision operators representing secondary medical knowledge support temporal interactions and complex revisions across multiple actionable graphs. The mitigation algorithm uses the actionable graphs, revision operators and available (and possibly incomplete) patient information represented in FOL. It relies on a depth-first search strategy to find a valid sequence of revisions and uses theorem proving and model finding techniques to identify applicable revision operators and to establish a management scenario for a given patient if one exists. The management scenario defines a safe (interaction-free) and preferred set of activities together with possible patient states.
Introduction
In 1990, the Institute of Medicine defined a clinical practice guideline (CPG) as "systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances" [1] . Subsequently there has been a significant increase in the number of published CPGs, in the research on methods for developing CPGs, and in the number of 5 studies on the use of CPGs in clinical practice [2, 3] . While initially CPGs were created in teaching hospitals and academic centers, now their development has moved to dedicated organizations such as the National Institute for Health and Care Excellence (NICE) in the UK or Cancer Care Ontario in Canada. There are easily accessible CPG repositories, such as the Agency for Healthcare Research and Quality National Guidelines Clearinghouse, and the Guidelines International Network 10 (GIN) was created to support collaboration in the development, adaptation, and implementation of guidelines.
Interest in CPG development and use inspired the health informatics community to work on methods for structuring CPG representations [4] and on computerizing textual CPGs so they can be automatically processed. This last line of research produced a number of guideline representation 15 languages, such as Asbru, GLIF, GUIDE, EON, and PROforma [2] . However, almost all of the research on guidelines is focused on developing and executing CPGs designed for the management of a single clinical condition while ". . . an emerging issue around which there is considerably less evidence or experience. . . (is) that . . . many patients do not just have single clinical condition" [5] .
Developing CPGs for patients with multi-morbidity is difficult because most of the clinical studies 20 used for guideline development exclude such patients from clinical trials [5] . From the medical perspective of CPG development, there were attempts to address this issue by making a distinction between the concordant morbidities -where similar therapies are followed, and the discordant ones -where morbidities have a different etiology and therefore require different and often conflicting therapies [6] . Similarly there is work that assess the multi-morbidity by linking the severity of a 25 disease and interactions with other morbidities [7] .
The research described in this paper considers discordant multi-morbidity and proposes a mitigation framework addressing adverse interactions resulting from conflicting therapies. Thus, we define the mitigation problem as the need to identify and address adverse interactions associated with applying multiple CPGs to the same patient, while taking into account the temporal char- 30 acteristics of the activities in the CPGs and patient preferences related to prescribed treatments.
To solve this problem, we propose a mitigation framework that provides a formal representation for the CPGs (considered as primary medical knowledge) and the secondary medical knowledge related to adverse interactions and patient preferences, and a mitigation algorithm to identify and address adverse interactions for a multi-morbid patient. Our work uses a "mitigation-oriented" 35 CPG representation that facilitates the mitigation of adverse interactions, while also allowing for many complexities supported by "execution-oriented" representations like those discussed in [2] .
In a comprehensive review of research on CPGs [3] , it was found that ". . . one unsolved research question is how can we concurrently apply multiple computer-interpretable guidelines to patients that have a comorbid clinical condition", and our earlier research [8] is quoted as one of few attempts to 40 answer this question. In that earlier work we proposed a mitigation algorithm to reconcile two CPGs for discordant conditions. This previous algorithm applied constraint logic programming to identify possible adverse interactions between actions indicated by two CPGs and revised these actions using secondary clinical knowledge. Since this research was published, we have made significant progress in creating a mitigation-oriented representation of the CPGs by using first-order logic (FOL) theories 45 and applying theorem proving and model finding techniques to process these theories. Early results of this research were published in [9, 10] . The rationale for moving to FOL as the foundation for a mitigation-oriented representation was stated as:
• The need for a more expressive representation of CPGs that introduces explicit precedence relations between actions and decisions and allows for parallel (simultaneous) actions and 50 decisions to be considered within a single CPG.
• The need for a more expressive representation of the secondary medical knowledge (encoded in the form of revision operators) that effectively handles extensive revisions in multiple simultaneously considered CPGs.
The above requirements were partially addressed in [9, 10] where we introduced predicates to 55 represent relations (precedence between actions and decisions) and properties of the actions (e.g., drug dosages). We also demonstrated how predicates impose semantic clarity and thus facilitate the clinical interpretation of the mitigation results. In the research described in this paper we broaden the scope of our approach by handling multi-morbidity, introducing temporal properties, and considering patient preferences during mitigation. To achieve this broader scope, we introduce 60 the following substantial changes to work described in [9, 10] 1. We extend the mitigation framework to allow for concurrent processing of multiple (more than two) CPGs and to consider patient's preferences with regards to prescribed treatments.
2. We improve the expressiveness of the CPG representation, to allow for parallel actions and decisions and to account for a number of their temporal properties, and of the secondary 65 knowledge representation so it can handle complex revisions of multiple CPGs.
3. We propose a mitigation algorithm that allows for the application of multiple revision operators that is insensitive to their ordering.
While this research focuses on the methodological aspects of mitigation, we also envision a practical application of our framework where a clinical user will be insulated from the rather complex FOL 70 representation and will be given a semantically meaningful summary of the results of mitigation (illustrated in the clinical case study in Section 5). The mitigation-oriented CPG representation will be obtained (semi-)automatically from many execution-oriented representations [11] or it will be created by a knowledge engineer from a paper-based guideline. Although the latter approach is quite challenging (see discussion in [3] ), it will need to be used infrequently, for example when a 75 new CPG is published or an existing one is significantly revised. The intervention of a knowledge engineer may also be required when a patient deviates from the management plan prescribed by a CPG -see our discussion in Section 6. We also note that our framework is representation agnostic and will work with any approach used to developing a mitigation-oriented CPG representation.
The revision operators used for mitigation are developed from various medical knowledge sources 80 (e.g., systematic reviews) with initial input from clinicians, later encoded into FOL by a knowledge engineer, and stored in a comprehensive repository. Finally, the mitigation algorithm invoked by a clinical user with partial patient data will automatically access relevant FOL-encoded CPGs, the repository of operators, and using theorem proving and model finding techniques will reason about the adverse interactions and required revisions. We imagine that an intelligent, semantically aware 85 interpreter will take the results of this reasoning and present them in a clear and simple form to the clinical user for decision making.
The paper is organized as follows. In the next section we describe related work. In Section 3 we briefly present the foundations of FOL. Section 4 introduces the mitigation framework and describes its components with a special emphasis on the mitigation algorithm. Application of the 90 mitigation framework is illustrated with a clinical case study presented in Section 5. This case study describes the treatment of a patient suffering from chronic kidney disease and hypertension, who experiences a sudden onset of atrial fibrillation. We finish with a discussion and conclusions in Section 6.
Related work
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Our framework mitigates adverse interactions between multiple CPGs applied to a multi-morbid patient. It introduces a mitigation-oriented CPG representation that on one hand captures the complex characteristic of CPGs (e.g., parallel activities and their temporal attributes), and on the other hand facilitates their processing by the mitigation algorithm. Moreover, the framework allows for the specification of patient preferences and considers them when addressing encountered 100 interactions and revising the applied CPGs. Thus, the most relevant related work to our approach falls into three areas: computer-based representation of CPGs, mitigation of interactions between CPGs in multi-morbid patients, and inclusion of patient preferences in health care, particularly in CPGs.
There is a body of research on execution-oriented representation of CPGs and we relate our work 105 to those representations that support complex guideline structures such as ordering and temporality of actions. Conditional branching and ordering of activities are supported in GLIF [12] , where it is possible to specify whether all, some, or only one of the activities must take place. In addition, one can specify whether the activities are to occur in a specified order or in parallel. The temporal nature of activities is considered in the META-GLARE system [13] that uses certain control attributes.
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Another example is PROforma [14] -a task network-based representation with formal semantics that has a limited number of task classes (enquiries, actions, decisions, and (compound) plans).
ASBRU [15] also supports time-oriented actions, conditions, and intentions as patterns of actions or treatment states to be considered during or at the end of a plan. Our mitigation framework supports all of these types of activities and their ordering by using actionable graphs (a mitigation-115 oriented task network-based representation described in Section 4.1) that can be derived from GLIF, PROforma as well as other similar CPG representation languages. Additionally, we support a set of temporal properties on actions and decisions that enable us to reason over their actual start and end times using available temporal information about time offsets, durations and start times of management associated with specific CPGs (described in more detail in Section 4.2).
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Mitigating and combining multiple CPGs has typically required experts and relied on an ontology as the representation paradigm [16, 17, 18, 19 ]. An interesting example of this line of research is the GLINDA system [16], which models activities and medical knowledge using an ontology of interactions in Protégé. It does not, as far as we are aware, provide reasoning capabilities over these interactions. The semantic web-based framework proposed in [17] also uses description logic and 125 an ontology mapping-based approach to merging representation ontologies. Similarly, the use of ontologies that define possible interactions and consider time has been proposed in [19] . These approaches offer less flexibility and reasoning capabilities than our FOL-based approach as described in Section 4. They provide a defined set of transformations and do not capture interactions that must be mitigated for some, rather than all instances of clinical actions in CPGs or that require 130 temporal reasoning to determine durations, start and end times, and overlaps of these actions. Furthermore, work described in [18] assumes uniform CPGs based on the same template and introduces specialized operators to combine corresponding template elements in pairs of CPGs. This reliance on pairings based on the same template limits the possible combinations of CPGs and as such is limited to co-morbidities. Our proposed approach applies to multi-morbidity with no limitations 135 on the structure of CPGs that can be considered concurrently.
Research on formalizing mitigation with answer set programming was proposed in [20] . However, as we show in Section 5, our proposed framework is applicable to multi-morbid patients while the approach proposed in [20] is limited to two CPGs, is more restrictive (does not support parallel clinical actions), and requires expert intervention during mitigation. The work by Zamborlini et 140 al. [21, 22, 23] describes Transition-based Medical Recommendation (TMR) models for discovering interactions between guidelines using semantic web technology, although temporal aspects and related interactions are not currently addressed [23] . In fact, they use case studies from our previous work [8] to demonstrate the applicability of their approach. We would like to note that TMR is complementary with our framework. In their recent papers [22, 23] to represent rules for discovering interactions between multiple guidelines -these rules could be included as applicability conditions in our generic revision operators.
Yet another approach to mitigating multiple CPGs is presented in [24] where this problem is cast as a multi-agent cooperative planning process. Individual agents create treatment plans driven by disease-specific CPGs and at the same time they coordinate these plans by sharing derived 150 recommendations and resolving eventual conflicts. This approach requires all CPG activities to be characterized with preconditions and effects resulting in a complex CPG representation, going beyond the popular task network-based languages mentioned above. The CPG representation introduced in our framework is simpler, albeit sufficiently expressive, and it employs the precedence relation to impose ordering on the activities.
155
The third area of related work is considering patient preferences when applying CPGs. Following [25] , for the purpose of this research we define patient preferences as perspectives, beliefs, and healthrelated goals that are used when considering the potential benefits and harms of the treatment options. Thus, we are not concerned with the vast body of research on patient-reported outcomes as described in [26] . Involvement of a patient in treatment decisions is a principal tenet of shared 160 decision-making. While shared decision-making is gaining attention in healthcare, there is still a challenge associated with the greater involvement of patients, both from the patient and provider perspectives [27] . One of the ways of addressing this challenge is through direct integration of patient's preferences into the CPG, as advocated in [28] . There is also a developing consensus that research evidence alone (i.e., CPGs) is not sufficient for effective and efficient patient care if it is 165 taken outside patient context that includes patient preferences with regards to treatment options [29, 30] . Information technology is considered to be a very useful tool for preference elicitation, a notion advocated for about 15 years ago [31] . Research that directly embeds preferences into clinical decision support is proposed in [32, 33] . In our work, patient preferences constitute one of the factors that control the mitigation process and they are used for customizing CPGs to meet the 170 needs of a multi-morbid patient. 
First-order logic
Mitigation framework
The proposed framework, outlined in Figure 1 , solves a mitigation problem for a multi-morbid 200 patient. The framework assumes that CPGs applied to manage the patient are represented as actionable graphs AG di [9] and it uses this representation during subsequent processing of the CPGs.
The mitigation framework adopts FOL for the internal representation of the mitigation problem and related knowledge. Specifically, it introduces a mitigation-specific FOL language L mit to describe core components of the mitigation problem (actionable graphs, available patient information), a 205 suggested treatment, and secondary medical knowledge related to mitigating adverse interactions and considering patient preferences.
The core components of the mitigation problem are brought together as a combined mitigation theory D comb expressed in L mit . D comb is processed by the mitigation algorithm that uses revision operators RO k codifying in L mit the secondary medical knowledge needed to identify adverse in-
210
teractions, to revise D comb , and to account for applicable patient preferences. Revision operators define conditions under which they are applied and describe revisions that address these conditions.
The mitigation algorithm generates a management scenario D ms -a theory in L mit that describes a preferable and interaction-free treatment of a patient and the patient's possible future state, or it provides a warning if D ms does not exist.
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The mitigation algorithm includes several specialized procedures and it uses theorem proving and model finding techniques as part of their execution. While most of the processing occurs at the FOL level, the mitigation algorithm uses regular expressions and find-and-replace operations to introduce changes to the textual representation of D comb . These techniques are often used in document retrieval, data analytics and database queries [37, 38] , and in our approach they allow 220 for non-monotonic revisions (e.g., removal or replacement of certain parts) of D comb that are not supported at the FOL level.
The main components of the mitigation framework are described in detail below.
Actionable graphs
An actionable graph AG di represents a CPG for managing disease d i (here we extend the notion 225 of a disease to include conditions such as trauma). AG di is a directed graph with context, decision, action, and parallel nodes where:
• a context node indicates the context of the CPG (disease d i ) and it is the root of the graph,
• a decision node indicates a clinical decision,
• an action node indicates a clinical action, and
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• a parallel node indicates the beginning or end of two or more sequences of activities (clinical decisions or actions) that are executed in parallel.
An actionable graph relies on the task network-based representation used as a foundation for a number of representation languages (e.g., GLIF3, SAGE or PROforma) [3] , however, it has been limited to those elements that are important from a mitigation perspective (in particular to the 4 235 types of nodes listed above). Specifically, we do not consider explicit data inquiry nodes -instead we assume selected patient information has already been collected and is provided in advance as input to the mitigation framework, so it can be accessed and checked at decision nodes. We showed in [11] that actionable graphs can be easily obtained from other task network-based languages and we use these graphs as an intermediate representation that allows us to apply our mitigation 240 framework to CPGs represented in these different languages.
In this work we expanded actionable graphs with temporal characteristics. Specifically, we introduced time offset and duration attributes for all types of nodes in AG di . The former provides the time-based offset of a given node from a preceding one, while the latter represents the duration of the activity associated with this node. We assume the time offset for the context node is 0
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(i.e., there is no preceding node) and the duration of the context and parallel nodes are fixed at 0 because there are no activities associated with these nodes. We also define the default value for the time offset and duration as 0 to indicate that unless specified explicitly, specific nodes immediately follow one after another and they are completed instantly. Note that from the clinical perspective it is sufficient to associate temporal attributes only with decision and action nodes. However, our
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proposed uniform representation eases the reasoning process as explained in the next section. 
Mitigation-specific FOL language
To develop a FOL-based description of a mitigation problem, we introduce a mitigation-specific
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FOL language L mit . Non-logical symbols in L mit include constants (used as labels for diseases, actions, decisions and their results) and predicates. Predicates are divided into structural and temporal ones. The structural predicates allow for capturing the structure of actionable graphs and they are given in Table 1 . In comparison to our initial proposal for these predicates (see [9] ), we now associate a variable and a label with each decision and action node, e.g., action (x, A) means
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that node x is associated with an action labeled A. In this way we are able to easily represent that a certain action (e.g., administration of a drug) may appear several times in a CPG -this simplifies the descriptions of possible revisions, as a single modification may be applied to all occurrences of this action. We also note that we do not need explicit representation for parallel paths and instead use parallel nodes to identify such paths in an actionable graph.
280 Table 1 : Structural predicates in L mit (d, t, a and v are labels identifying a specific disease, decision, action, and result respectively; dosage is given in logical units)
Predicate Description
x is a node in an actionable graph
x is a decision node associated with decision t action(x, a) x is a action node associated with action a parallel(x) x is a parallel node directP rec(x, y) node x directly precedes node y (there is an arc from x to y)
prec (x, y) node x precedes y (there is a path from x to y) dosage(x, n) dosage of the drug administered in an action node x is n units result(x, v) result of the decision made in a decision node x is v
The temporal predicates are given in Table 2 . The first two -timeOffset and duration -were explained in the previous section. The startTime predicate specifies the start time of an activity associated with a given node. The start time of the context node indicates when the management according to the CPG has been initiated and it needs to be provided as part of patient information, while the remaining start times are established automatically using time offsets and durations 285 associated with specific nodes. The currentTime predicate allows for specifying the current time point in the patient management process. Finally, the last three predicates identify temporal relations between actions from multiple CPGs and are derived automatically based on start times, the current time, and the durations of specific activities associated with the nodes. Predicates that indicate temporal overlapping of activities (overlap and overlapN owOrLater) interpret time 290 intervals consistently with Allen's interval algebra [39] and they combine several original relations, such as overlaps, starts, during or finishes. Predicate Description timeOffset(x, to) node x occurs to time units after the preceding node duration(x, dt) node x takes dt time units to complete startT ime(x, st) node x starts at time st currentT ime (ct) current patient time is ct happensN owOrLater (x) activity (decision or action) from node x is happening now (given current time) or will happen in future overlap (x, y) execution periods of nodes x and y overlap overlapN owOrLater (x, y) execution periods of nodes x and y are overlapping now (given current time) or will overlap in the future
Combined mitigation theory
A combined mitigation theory D comb brings together the core components of a mitigation problem. Specifically, D comb is a collection of three FOL theories formulated in L mit and it is represented as a triple:
where
• D cpg is a theory that describes the actionable graphs representing CPGs used to manage 295 a multi-morbid patient. Formally, D cpg is a union of m theories, each describing a single theories. In Figure 3 we present example axioms in D common , specifically those that are used to automatically establish selected temporal predicates from endT ime provides no new semantics (it is simply derived from the start time and duration -see axiom 1), but it allows for the simplification of the other axioms (see axiom 2). The notational complexity of axiom 3 is due to it needing to account for multiple preceding nodes and to select the most recent one in order to establish the start time for the current parallel node. have been proposed in the literature -see for example [40] ). Logical formulas corresponding to paths (path formulas in short) are combined into a single sentence using a recursive procedure.
The procedure starts with a set of path formulas corresponding to all paths in AG di , and traverses 325 formulas from the current set until it encounters a decision node or a parallel node, or it reaches a terminal node. If it encounters a decision node or parallel node, then (1) it splits the current set of path formulas into subsets corresponding to arcs starting at the current node (all paths in a subset share the same outgoing arc), (2) combines these subsets using a disjunction for a decision node and conjunction for a parallel node, and (3) recursively combines each subset of path formulas.
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The obtained formula is turned into a sentence by adding an existential quantifier over variables associated with specific nodes. These variables are then used to trace the traversal through D di cpga model finder instantiates only those variables that correspond to visited nodes. While listing all paths in AG di is verbose, it facilitates their processing (see Section 4.7 for details). Moreover, this verbose representation can be easily simplified by using Boolean algebra.
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As an example, in Figure 4 we show the graphical representation of all paths obtained from Figure 2 -there are 4 paths denoted as P1..P4 (for simplicity we do not repeat the characteristics of the nodes). In Figure 5 we present the path formula corresponding to P1 (formulas for the remaining paths can be easily derived from Figure 4 ). The initial set of 4 path formulas is split into two subsets (corresponding to paths P1 and P2, and P3 and P4) -this split is implied circumstances (e.g., a sequence of actions) that are not consistent with patient preferences and describe revisions that modify actionable graphs according to these preferences.
The formal definition of a revision operator is the same for both classes. Specifically, a revision operator RO k is defined as:
where 355
• α k is a logical sentence in L mit that describes the undesired circumstances for which the operator is applicable -we refer to these circumstances as the applicability condition (for interaction-related operators α k describes an adverse interaction, and for preference-related operator it describes violated patient preferences),
• Op k is a list of n operations Op k,i (i = 1 . . . n) that need to be applied to D cpg in order 360 to revise it so that the applicability condition α k has been addressed (other components of Each Op k,i describes a single find-and-replace operation and is formally defined as a 4-tuple:
where be set to an empty formula ε to support insertion and deletion, thus Op k,i models the following revisions (they are also illustrated in Figure 6 ):
should be replaced by ψ k,i ,
should be deleted.
Additionally, in replacement and deletion operations the location of modifications in D cpg can be specified partially or it can be omitted -specifically, γ k,i and/or δ k,i can be set to ε. This allows
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for global revisions where all occurrences of φ k,i are replaced by ψ k,i or deleted.
A revision operator RO k may be possibly or certainly applicable to a combined theory D comb . definite applicability are illustrated in Figure 7 using a simple example of a patient suffering from two diseases and evaluated at two different moments -before and after making a treatment decision. We use the RO k int and RO k pref symbols in order to distinguish between interaction-and preferencerelated revision operators respectively. Wherever such a distinction is unnecessary (e.g., the description applies to both classes), we use the RO k symbol. along with their timing (startT ime, and duration predicates), and includes the assumptions made about the patient's future state (result predicates).
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Obtaining new patient information triggers a repeated application of the mitigation framework and can result in a new management scenario. A physician evaluates D ms by checking the appropriateness of the assumptions made, and if she deems some of these assumptions to be incorrect, new patient information needs to be collected and provided and the mitigation algorithm needs to be activated again to generate a new management scenario. 
Mitigation algorithm
The mitigation algorithm is outlined in Figure 8 . It consists of three procedures: customize, mitigate, and revise, and uses two external tools -a theorem prover and a model finder. The theorem prover is used to check the consistency of a combined theory and the applicability of revision operators, while the model finder is used to identify models of a combined theory that In the subsequent sections we describe the two procedures that operate on the FOL level, as they are essential for the mitigation framework. Processing at the regular expression level is relatively simple (from a conceptual perspective) and includes multiple translation (between FOL and regular formulas from D cpg that correspond to current or future activities, because it is not reasonable to modify parts representing past activities. Given the technical and auxiliary character of the revise procedure, we omit its detailed presentation from this paper. We note that because preference-related revision operators are applied sequentially in order of their decreasing priority, it is possible that preference-related revisions introduced earlier "block" preference-related revision operators with lower priorities (i.e., due to revisions in D comb they are no 460 longer applicable). Moreover, since preference-related revisions that introduce conflicts are skipped over, they can be seen as "soft constraints" -they are desired, but not strictly required. In the future we plan to develop a method to maximize the expected value of applied preference-related revisions using the patient's value function rather then a prioritization of operators.
The main loop of the procedure is repeated as long as any preference-or interaction-related re-visions have been introduced to D comb . This approach handles situations where initially preferencerelated revision operators are not applicable to D comb , however, they become applicable after introducing interaction-related revisions. This situation is illustrated in a clinical scenario in Section 5.2.2.
Mitigate procedure
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The goal of the mitigate procedure is to identify those adverse interactions encountered in D comb that are described by interaction-related revision operators, to revise D comb by applying operations described by appropriate operators, and to create a management scenario D ms . The pseudo-code of the mitigate procedure is given in Figure 10 (it also includes an auxiliary expand procedure). The procedure employs recursive depth-first search to identify a sequence of revisions 475 that address all encountered adverse interactions and it is able to backtrack from a sequence that results in a failure. In this way the mitigate procedure is able to handle situations when an interaction-related operator introduces new conflicts. These conflicts are either addressed in subsequent iterations of the procedure and a feasible sequence of revisions is found, or they can not be addressed (e.g., due to incomplete secondary knowledge) leading to failure. In the latter case, the 480 search will backtrack to the state where the questionable operator has been applied and another sequence will be explored. The ability to backtrack makes the mitigate procedure independent of the order in which mitigation operators are applied, as it will find a non-failure sequence of revisions if such a sequence exists. A potential drawback of the implemented search technique is related to its theoretical computational complexity -in the worst case search may need to explore all possible 485 permutations of applicable revision operators. However, apart from the fact that the number of interaction-related operators is relatively small in practice, in experimental evaluations depth-first search has shown acceptable performance even for complex problems [42] . Dms := null; Subsequently, the mitigate procedure is invoked recursively using modified parameters to continue search (line 19). If a valid sequence of revisions has been found and D ms has been created, the procedure terminates by returning the revised theory D comb (lines [21] [22] .
Once the loop over interaction-related revision operators has completed, the procedure checks if a terminal search state has been reached (i.e., mitigate has not been recursively invoked) and the failed list is empty (line 23). If these conditions are satisfied, then D comb is temporarily expanded into D exp comb , a model I for the latter theory is found by the model finder and filtered into D ms by focusing on the current and future action and decision nodes (lines 24-26). Otherwise, the procedure fails to find a management scenario due to failed revisions (line 28).
Clinical case study
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Chronic kidney disease (CKD), according to the guideline published by the Ministry of Health of British Columbia [43] , is defined as "an abnormality of kidney structure or function that is present for longer than 3 months". CKD is a very serious medical condition and its severity is determined by analyzing the results of the estimated glomerular filtration rate (eGFR). Progression of CKD is measured in stages (from 1 to 5) depending on the eGFR value for a patient. Patients with 530 advanced CKD, such as those having significantly impaired kidney function that requires dialysis, have very poor health outcomes -their 5 years survival rate is worse than for most cancers. Usually a CKD patient also has hypertension (HTN) and suffers from some form of cardiovascular disease, or is at a high risk of developing this disease. Both patient cases presented in this study involve multi-morbid patients with CKD and HTN who suffer from atrial fibrillation (AFib), common 535 multi-morbidities for this patient population. These cases were created by a clinical expert on our team (hematologist) who also evaluated and vetted the management scenarios. (Figure 11 ), where the value of eGFR is checked, is associated with the x2 variable and EGF R label. For the sake of brevity, in all actionable graphs we explicitly indicate only those values of temporal attributes that are different than defaults (timeOf f set = duration = 0). For example, in AG AF ib ( Figure 12 ) the duration of the action to 545 administer flecainide (variable x6, label F LEC) is 1 day and this action occurs without delay after the preceding one. We express all time-based properties of actions using either days or weeks (they are converted to a common unit in the processed D comb theories) and we use a special value for duration -inf inite -that indicates life-time actions (a common situation in chronic diseases -in fact, most of the actions in the presented actionable graphs have this property). Obviously, such 550 infinite duration can be associated only with terminal action nodes in actionable graphs (i.e., action nodes that are leaves in an actionable graph). We also assume that all dosages of administered drugs are optimized for efficiency -for brevity this information has been omitted from the actionable graphs, but it is included in the D di cpg theories. In Section 5.2.2 we show revisions affecting dosages and adjusting them from the optimized level. The D CKD cpg theory obtained from AG CKD is given in Figure 14 . Due to the verbosity of the FOL-based representation, we show only the formula corresponding to the left-most path from AG CKD . It specifies time-based attributes for all nodes in this path and dosages associated with all action nodes (here we use the special optimized value to indicate optimized dosages).
Actionable graphs and revision operators
∃x1, x2, x3, x4, x6, x7, x8, x9, x10, x11, x12, x13, x14, x15, x16 : Finally, in Table 3 we provide a textual description of interaction-related revision operators that In Figure 15 we show the FOL-based representation of the RO 2 int operator and graphically illustrate 565 the changes it introduces. RO 2 int replaces an action node corresponding to the administration of diuretics and incoming and outgoings arcs with a single arc effectively eliminating diuretics from patient management. If patient is diagnosed with CKD and AFib, and is prescribed initial (optimized) dosage of dabigatran (300 mg), then decrease the dosage to 220 mg whenever dabigatran is administered. cpg , and these two nodes overlap in such a way that the first node starts no earlier than the second node and it ends no later than the second node, than remove the first node. cpg , and these two nodes overlap in such way that the first node starts before the second node and it ends before the second node ends, then postpone the start of the second node until the first node ends and shorten the duration of the second node accordingly. int -are more generic as they are associated with adverse interactions caused by overlapping duplicates of an action from multiple 570 guidelines. Revisions defined by these operators are currently limited to removing specific action nodes or changing their temporal attributes, however, they can be easily extended to introduce additional modifications, like adjusting drug dosages. In Figure 16 we graphically illustrate revisions introduced by RO 9 int ). It adjusts the time offset of the second instance of action A to make it start just after the first instance. Moreover, the operator shortens the duration of the second instance of 575 A, thus the end time does not change. Due to these revisions an overlap between two instances of the same action is eliminated. 
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currentT ime (t0) . The subsequent iteration of the main loop in the customize procedure introduces no changes to 610 D comb , therefore, the procedure terminates and D ms is established by the mitigate procedure and returned. The management scenario is given in Figure 18 (for brevity we omitted information about optimized drug dosages). In layman's terms, it asks for the continuation for another 9 weeks of the 2nd phase of management for HTN that started 3 weeks ago, assumes blood pressure becomes controlled after this phase, and advises lifestyle management. For AFib, D ms prescribes 615 long term treatment involving a selective beta blocker, a calcium channel blocker, and warfarin.
Administration of the selective beta blocker and warfarin starts immediately, and the calcium channel blocker starts in 9 weeks to avoid overlapping with the treatment for HTN, Finally, for CKD, D ms prescribes an ACE inhibitor that similarly to the calcium channel blocker starts in 9 weeks. 
Case 2 -a CKD and HTN patient experiences paroxysmal AFib
In this scenario we consider a 70-year old male already treated for CKD and HTN -the management for CKD was initiated 3 years ago, while HTN was diagnosed only 7 months (28 weeks) ago. The patient's kidney function has been severely decreased (eGFR < 60, stage 3 of CKD) and while he has suffered from anemia, his ferritin level is acceptable (> 100 ng/ml); moreover, he does currentT ime (t0) . preference-related revision operator (its textual representation is given in Table 4 ) that is considered together with the interaction-related revision operators from Table 3 . In order to establish the management scenario, after the D comb theory is constructed, the mitigation algorithm invokes the customize procedure. Initially RO 1 pref is not applicable to D comb (due to the CHA 2 DS 2 -V ASc equal to 0, the patient is prescribed aspirin), and the unmodified D comb 640 is passed to the mitigate procedure. This procedure explores possible combinations of applicable interaction-related revision operators from Table 3 IN F IN IT E) . 
Discussion and conclusions
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In this paper we proposed a comprehensive FOL-based mitigation framework for the concurrent application of multiple CPGs to a multi-morbid patient. The framework handles discordant morbidities and incorporates patient preferences. Specifically, it customizes CPGs represented as actionable graphs to a specific patient by revising them using revision operators to address adverse interactions and unmet patient preferences. Finally, it creates a management scenario that includes 675 activities that are clinically appropriate and preferred by the patient. As such, the framework can be used as a simulation and verification tool supporting a physician in planning a complex therapy for a multi-morbid patient.
The mitigation framework extends our earlier work [9, 10, 44] and includes the new elements summarized below: We illustrated the operation of the mitigation framework using two clinical cases describing patients suffering from chronic kidney disease, hypertension, and atrial fibrillation. We would not have been able to handle these clinical cases without the extensions described in the paper.
To the best of our knowledge, our proposed framework is one of a very few attempts to consider 710 time when mitigating adverse interactions in multiple CPGs. Although it shares some similarities with the approaches described in [19, 45] -specifically, it considers similar temporal attributes characterizing actions and decisions in a CPG, it differs in some important aspects. We use the FOL-based representation with interactions (both temporal and non-temporal) captured by revision operators, while the other approach relies on ontological models. On one hand, ontological models 715 provide a comprehensive representation of the entire domain knowledge, but on the other hand, our revision operators due to their isolated nature (each describes a specific adverse interaction and the way to address it) allow for "chunking" knowledge, and thus its easier management and maintenance [3] . Furthermore, [19] formulates a simple temporal problem (STP) to detect temporal relationships.
This temporal constraint formulation allows for partially specified temporal relationships and would 720 serve as a nice relaxation of the assumptions made by our proposed approach.
Our approach is complementary to the research proposed by Zamborlini et al. [21, 22, 23] . We could leverage the reusability of their revision models while providing support for temporal aspects of the mitigation problem (they currently do not support these) and applying revisions to determine if any interactions still exist (they only identify and suggest revisions). Our proposed framework also 725 handles both preferences and adverse interactions in a uniform manner, while other related work manages adverse interactions only. Finally, our logic-based framework is one of the first approaches using formal methods to identifying and addressing multi-morbidities. New research in this area includes the recently published work by Somekh et al. [46] that proposes comparative simulation of comorbidities, using stochastic Petri nets, to examine the actual and potential phenotypic effects 730 of perturbation of a network known to be involved in comorbidities to predict new roles for genes in the comorbid conditions. Limitations of our proposed mitigation framework include:
1. In the actionable graph we do not use the data inquiry node that is present in other task network-based representations and instead use a decision node as a proxy for patient data.
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Specifically, we rely on summarized patient data instead of using individual data items (for example, instead of asking for a blood pressure value, we ask if hypertension is controlled or not). Therefore, we are not able to discover redundancy in data collection and treat it as a potential interaction to be mitigated. Also, we are not able to process complex conditions in a decision node (i.e., comparison of patient data collected at different time points). 740 2. Expressiveness of revision operators (in particular their applicability conditions) is a function of the mitigation-specific FOL language described in Section 4.2. While this language allows for encoding operators that are applicable to multiple diseases (like operators RO 8 int and RO 9 int presented in Section 5.1), its expressiveness is not as rich as that of the TMR models proposed by Zamborlini et al. [21, 22, 23] . To illustrate this limitation, in order to capture 745 interactions between classes of drugs we would need to use multiple operators instead of a single one.
3. The proposed mitigation framework is sensitive to deviations from the therapies prescribed by a CPG. In order to assure correctness of the reasoning, we assume that the patient management process follows exactly what is in the CPGs (original or revised ones). Thus, if there 750 are any "external" changes to the therapies, the actionable graph needs to be "synchronized" manually by introducing these changes before the mitigation algorithm is invoked. 4 . In situations where an interaction-free management scenario does not exist, the proposed mitigation framework is not able to provide explanations about the revisions that were attempted or about the sources of conflict.
755
We are working on addressing the limitations listed above. We are looking at expanding the mitigation-oriented representation with the data enquiry node associated with additional temporal attributes such as validity of collected patient data items. This expansion would allow us to identify possible redundancies in patient data collection, specify complex conditions in decision nodes, and reason over patient data similarly to argument-based decision making used in PROforma or SAGE 760 [3] . We will expand the mitigation-specific FOL language with additional predicates (e.g., corresponding to classes of drugs and actions) for improved expressiveness and generality of the revision operators. We are also looking at introducing a "pre-check" step to the mitigation algorithm to identify possible deviations between the CPG and current patient's therapy and to semi-automatically address these changes by suggesting them back to the mitigation-oriented representation of applied 765 guidelines. Finally, we are working on expanding the mitigation algorithm so it provides explanations of the management scenario or lack thereof. In this work we are returning solutions similar to what we used in our earlier research [8] . However, we are considering keeping track of the revision operators that have been applied but led to failure in the customize and mitigate procedures, so this information can be used by the explanation facility of the mitigation algorithm.
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As part of future research we also plan to examine the impact of ordering revision operators on the effectiveness of the mitigation algorithm. As such, we will be comparing the current strategy based on the depth-first search with several other approaches to analyzing and ordering revisions to determine the most appropriate one. Some of these competitive approaches will include a heuristic-based approach to ranking revisions operators, or a formal analysis to determine the 775 suitable ordering of revision operators based on their characteristics. Finally, we are also planning to expand the temporal attributes associates with nodes in the actionable graph to allow for imprecise or probabilistic specifications (e.g., by defining probability distributions over possible time offsets or durations). This will enable us to capture temporal complexity and uncertainty inherent in some real-world clinical scenarios.
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While our work here focused on the methodology and the proposed mitigation framework is presented using a theoretical perspective, below we provide an overview of how it can be used in clinical practice. This overview is summarized in Figure 21 . The high-level implementation involves two architectural components -the mitigation clinical decision support system (CDSS) and the FOL-based knowledge repository. The mitigation CDSS is responsible for computations, i.e., processing of combined mitigation theories, and for interfacing clinical users (physicians) and an electronic patient record (EPR). Its mitigation subsystem executes the mitigation algorithm described in Section 4.7 and invokes an external FOL solver (Z3 [47] ) for theorem proving and model finding. Moreover, the run-time interface subsystem has a data capture facility for entering patient information and for importing it from the EPR through standardized protocols like HL7.
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The run-time interface subsystem reports detailed mitigation results (management scenario, applied revision operators). For better comprehensibility these results would be translated into a narrative, textual format, so the clinical user is fully insulated from the underlying FOL-based representation.
The FOL-based knowledge repository stores the knowledge used by the mitigation framework.
Specifically, it is divided into three sub-repositories with actionable graphs, revision operators and 795 patient information. The first two sub-repositories need to be prepared in advance and preloaded with the encoded primary and secondary medical knowledge. This process is conducted by a knowledge engineer who works with a clinical expert to elicit knowledge from textual CPGs, medical literature and the expert herself, and to encode it in FOL. While knowledge elicitation and encoding requires significant effort and time, it needs to be conducted before system deployment 800 and repeated only when significant updates are necessary (e.g., new CPGs are published). The subrepository with patient information is accessed by the mitigation CDSS during regular execution that automatically retrieves and updates its content.
The knowledge engineer may be also consulted by the physician during regular operation in order to encode patient preferences into preference-related revision operators. Again, this should happen 805 infrequently, for example when the management of a specific patient starts (or when her preferences have changed), and then the mitigation CDSS will use the defined operators. Thus, although the interventions by the knowledge engineer are crucial for the proper operation of the mitigation CDSS, they should be relatively infrequent and for the most part the CDSS will be interacting with physicians and automatically performing computations based on provided information. The described implementation of the mitigation framework comes with potential challenges.
One of them is associated with theoretical undecidability of theorem proving [48] . However, it was never encountered when testing the proof of concept implementation using different CPGs and patient scenarios. The other is related to the maintenance of the knowledge base. This maintenance requires the knowledge engineer to ensure knowledge consistency -this process can be facilitated by 815 using measures of inconsistency [49] to identify and void undesired consequences of the modifications to the knowledge base.
Our long term research plan is the full implementation and deployment of this mitigation framework within the MET decision environment [50] in the form of a mobile CDSS. This will also include an evaluation of the deployed system by physicians in a simulated hospital environment using paper 820 patients. Ultimately, we aim at integrating the proposed mitigation framework with our method-ology for supporting workflow execution by healthcare teams [51] -this integration would allow us to identify and address interactions that occur when a patient is managed by an interdisciplinary team according to several workflows and to consider patient preferences when executing tasks from these workflows.
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